Pfizer stock faces CFO exit near its 52-week low

Published on 10/07/2026 at 05:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pfizer stock traded at INR 3,852.20 on NSE on October 6, 2026, 1.6 percent above its 52-week low. CFO Amit Agarwal leaves on October 8.

Pfizer, INE182A01018, Illustration mit AI erstellt.

Pfizer stock (ISIN INE182A01018) was last at INR 3,852.20 on the NSE on October 6, 2026 at 3:29 p.m. IST, up 0.26 percent from the previous close and 1.6 percent above its 52-week low of INR 3,792.10. The next company-specific checkpoint is the departure of CFO Amit Agarwal on October 8, 2026.

CFO exit starts October 8

According to Scanx on October 3, 2026, Agarwal will leave his executive director, finance and CFO roles at the close of business on October 8. The filing also covers his seats on the corporate social responsibility, risk management, and board administration committees.

The transition follows a period in which Pfizer Limited is combining product launches with changes to its commercial approach. The market is therefore weighing operating growth against a management handover that takes effect within one day of the publication date.

Q1 revenue rose 8.3 percent

Sahi Markets reported that Pfizer Limited generated INR 653.17 crore of operating revenue in Q1 FY27, up 8.3 percent from INR 603.05 crore in Q1 FY26. Standalone net profit reached INR 204.47 crore, a 6.6 percent increase from INR 191.75 crore.

The Q1 comparison is the clearest operating counterweight to the leadership change. The same September 7, 2026 report said Pfizer Limited will receive a one-time INR 131.38 crore transition payment after discontinuing Minipress XL in India, although that inflow is separate from recurring product revenue.

Broker target sits 51.0 percent higher

In a report dated July 29, 2026, ICICI Securities retained a Buy recommendation and a target price of INR 5,815, according to DSIJ. The target lies 51.0 percent above the INR 3,852.20 NSE price, while the report linked its view to product launches and margin development.

DSIJ also reported Q1 FY27 EBITDA of INR 248 crore and an EBITDA margin of 37.9 percent, up 308 basis points year over year. That margin expansion gives the stock a measurable operating support, but the Minipress decision and the CFO transition keep execution central to the next update.

Pfizer stock stays near yearly low

Pfizer stock was last at INR 3,852.20 on the NSE on October 6, 2026 at 3:29 p.m. IST, with a 52-week range of INR 3,792.10 to INR 5,578.50 and market capitalization of INR 176.2 billion.